GCC Cas9 Technology Market

ID: MRFR/ICT/63085-HCR 200 Pages Aarti Dhapte Last Updated: August 24, 2026
GCC Cas9 Technology Market Research Report By Application (Genome Engineering, Disease Models, In Vitro Genetic Depletion), By Product Type (Consumables, Vectors), By Delivery Method (Physical Delivery Methods, Viral Delivery Methods, Non-Viral Delivery Methods) and By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes) - Forecast to 2035
GCC Cas9 Technology Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)8.59%
2024 Market Size$ 69.3 Million
2025 Market Size$ 75.25 Million
2035 Market Size$ 171.62 Million
Key Players
Editas Medicine
CRISPR Therapeutics
Intellia Therapeutics
Caribou Biosciences
Cellectis
Regeneron Pharmaceuticals
Trends
  • Increased Investment in R&D
  • Regulatory Developments
  • Collaborative Initiatives
Opportunities
  • Advancements in Genomic Research
  • Regulatory Support for Gene Editing
  • Growing Demand for Precision Medicine
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Information and Communications Technology, BY Type (USD Million)
      1. 4.1.1 Consumables
      2. 4.1.2 Vectors
    2. 4.2 Information and Communications Technology, BY Application (USD Million)
      1. 4.2.1 Genome Engineering
      2. 4.2.2 Disease Models
      3. 4.2.3 In Vitro Genetic Depletion
    3. 4.3 Information and Communications Technology, BY Delivery Method (USD Million)
      1. 4.3.1 Physical Delivery Methods
      2. 4.3.2 Viral Delivery Methods
      3. 4.3.3 Non-Viral Delivery Methods
    4. 4.4 Information and Communications Technology, BY End User (USD Million)
      1. 4.4.1 Biotechnology & Pharmaceutical Companies
      2. 4.4.2 Academic & Research Institutes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Information and Communications Technology
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Information and Communications Technology
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Editas Medicine (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 CRISPR Therapeutics (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Intellia Therapeutics (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Caribou Biosciences (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cellectis (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Regeneron Pharmaceuticals (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Beam Therapeutics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Precision BioSciences (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GCC MARKET ANALYSIS BY TYPE
    3. 6.3 GCC MARKET ANALYSIS BY APPLICATION
    4. 6.4 GCC MARKET ANALYSIS BY DELIVERY METHOD
    5. 6.5 GCC MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
    9. 6.9 DRIVERS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    11. 6.11 SUPPLY / VALUE CHAIN: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    12. 6.12 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY TYPE, 2024 (% SHARE)
    13. 6.13 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 (% SHARE)
    15. 6.15 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 TO 2035 (USD Million)
    16. 6.16 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DELIVERY METHOD, 2024 (% SHARE)
    17. 6.17 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DELIVERY METHOD, 2024 TO 2035 (USD Million)
    18. 6.18 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 (% SHARE)
    19. 6.19 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY DELIVERY METHOD, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

GCC Cas9 Technology Market Segmentation

GCC Cas9 Technology Market By Type (USD Million, 2025-2035)

  • Consumables
  • Vectors

GCC Cas9 Technology Market By Application (USD Million, 2025-2035)

  • Genome Engineering
  • Disease Models
  • In Vitro Genetic Depletion

GCC Cas9 Technology Market By Delivery Method (USD Million, 2025-2035)

  • Physical Delivery Methods
  • Viral Delivery Methods
  • Non-Viral Delivery Methods

GCC Cas9 Technology Market By End User (USD Million, 2025-2035)

  • Biotechnology & GCC Cas9 Technology Market Companies
  • Academic & Research Institutes

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.